Article
Genetically Adjusted PSA Levels for Prostate Cancer Screening
2022-04-21
Abstract excerpt
<h4>ABSTRACT</h4> Prostate-specific antigen (PSA) screening for prostate cancer remains controversial because it increases overdiagnosis and overtreatment of clinically insignificant tumors. Accounting for genetic determinants of constitutive, non-cancer-related PSA variation has potential to improve screening utility. We discovered 128 genome-wide significant associations ( P <5×10 -8 ) in a multi-ancestry meta-a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dfc14aa5-10ac-51d1-9ad5-3f7b2c2413b8
- DOI
- 10.1101/2022.04.18.22273850
